BTIG shares its Nike stock outlook ahead of next week’s earnings

BTIG’s Nike thesis centers on operating-margin recovery to above 12% from roughly 6.5%, driven by product mix, lower promotions and tighter inventory, despite a slow sales recovery. Consensus forecasts FY2027 revenue of $45.53B, below FY2026’s $46.40B, before a modest rise to $47.09B in FY2028; EPS is expected to increase from $1.70 to $2.13. Nike has beaten EPS expectations in each of the past four quarters, but negative post-results reactions and continued negative estimate revisions underscore investor concern over weak revenue momentum.

Analysis

NKE’s equity debate is shifting from whether earnings can recover to whether the recovery deserves a higher multiple. Cost, inventory, and mix actions can lift EPS quickly, but a margin-led beat without evidence of full-price sell-through risks being treated as a harvesting strategy rather than brand restoration. The relevant KPI is therefore not EPS alone: watch North America digital/wholesale growth, gross-margin progression excluding one-time supply-chain effects, inventory growth versus sales, and the proportion of sales sold at full price.

Competitive dynamics are unfavorable to a purely internal fix. HOKA (DECK), On (ONON), and Deckers’ UGG business continue to compete for premium consumer wallet and shelf space, while adidas (ADDYY) has been improving its product cycle; Nike must spend into running innovation and demand creation precisely as it is attempting to protect margins. That creates a likely 1-3 quarter tension: either investment depresses the near-term margin narrative, or underinvestment leaves revenue recovery vulnerable. Wholesale channel restoration could also transfer bargaining power to retailers such as DKS and FL, limiting the durability of gross-margin gains.

At a depressed share price, downside is increasingly tied to another reset in FY27 revenue or a failure of the next earnings release to validate improving demand—not simply to modestly weaker reported EPS. The contrarian upside is that low expectations make even stable revenue guidance plus demonstrable inventory normalization sufficient for a sharp rerating; however, the prior negative post-earnings reactions imply investors need forward demand proof, not another cost-control beat. A 6-18 month structural recovery remains plausible, but only if brand investment produces growth before competitors lock in consumer and distribution gains.

Key Decisions for Investors

• Remain neutral-to-underweight NKE into the next earnings report; do not add solely on an EPS beat. Cover the underweight if management guides FY27 revenue decline no worse than consensus while North America sales and full-price sell-through visibly improve.
• Use a tactical long NKE only after confirmation of revenue guidance stabilization: target a 10-15% rerating over 1-3 months if the company delivers positive North America growth and gross-margin expansion without inventory rebuilding. Exit if FY27 revenue guidance is cut again or inventory growth exceeds sales growth.
• Express the competitive-risk view as long DECK or ONON versus short NKE over the next two earnings cycles, sized modestly. The pair works if premium athletic demand remains healthy but Nike-specific execution lags; invalidate if Nike’s running category materially outgrows either peer for two consecutive quarters.
• Monitor DKS and FL as second-order beneficiaries of Nike’s wholesale re-engagement, but treat as watch items pending evidence of better retailer allocations and sell-through. A wholesale-led recovery can support their traffic and merchandising economics, although incremental Nike margin may be shared with the channel.